TQ-B3203
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 03, 2023
Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors.
(PubMed, Front Pharmacol)
- "BMI, LBW and DBIL were significant covariates that affected the pharmacokinetics of TQ-B3203. This model could provide references for the dose regimen in the future study of TLI."
Journal • Metastases • PK/PD data • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1